Kolyadina, I. V. Ribociclib in the treatment of HR+ HER2-negative metastatic breast cancer: Updated results from the randomized clinical trials and their role in the clinical practice. ABV-press.
Chicago Style (17th ed.) CitationKolyadina, I. V. Ribociclib in the Treatment of HR+ HER2-negative Metastatic Breast Cancer: Updated Results from the Randomized Clinical Trials and Their Role in the Clinical Practice. ABV-press.
MLA (9th ed.) CitationKolyadina, I. V. Ribociclib in the Treatment of HR+ HER2-negative Metastatic Breast Cancer: Updated Results from the Randomized Clinical Trials and Their Role in the Clinical Practice. ABV-press.
Warning: These citations may not always be 100% accurate.